Alembic Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
821.00
-8.65 (-1.04%)
BSENSE

Aug 10

BSE+NSE Vol: 88.87 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 807696,
    "name": "Alembic Pharma",
    "stock_name": "Alembic Pharma",
    "full_name": "Alembic Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/alembic-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "821.00",
    "chg": -8.65,
    "chgp": "-1.04%",
    "dir": -1,
    "prev_price": "829.65",
    "mcapval": "16,336.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 533573,
    "symbol": "APLLTD",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE901L01018",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "88.87 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/alembic-pharma-807696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alembic Pharma Q1 net profit up 12.1% at 173.07 cr",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-04 16:53:49",
        "description": "Alembic Pharma Q1 net profit up 12.1% at 173.07 cr  BusinessLine..."
      },
      {
        "title": "Alembic Pharma Q1FY27 results: Net profit rises 12% to 173 crore",
        "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxOc1lEOExJZ0Z2QVVScUdGd1BIdHVzbHB4MENTbFNYcmVYOVBoVjh1allEeU1BZjlmSFZQS3JLbXE1WHltSWlVRTZUOTJicHBaMzVEcXlpeDdfbDhiYTFDdkRyakJDZTlFRmJLQ19VaEZMa2hzMjRMMDgzYnc1MEtaV0pLRUZjS3Vvd1JiRkRCWVFwMVJXbXltTVB5QnNfcklLb01xbnFfaVU4Q3Rfa19vdTVPdE1BRU5uTmhBbl8tS1ZyUDBmV09JTTFsQVZTWmEtU08yMlRtYjVGZVhj0gHiAUFVX3lxTE9HVXNGSENsSUFiUktkSElJT1kwOEdMdG5XY0pUR0ozMkJsajl5U0paMkJ0S01NajY4ZXA2WEVqcjRDdDhPMWhSeDRXZlZpMTJJSmtybVQzRDYySFA3UE9ReEljUGlkVTl6UGpXNDlyYldMM2dWWl9JdnZObjBLcnlaS1kzTTZDY2dkZDhNNkpWOFZYcHlmRkt3ekduT0NLcl9sSUs5SFRtVURYc1d3T0lZWTZBNFk2UWNJbGNaODh4R3J4VlJTcEp3OUF6Xy1SQmpnenpRWDFscTNBWGNyRGhobXc?oc=5",
        "imagepath": "",
        "date": "2026-08-04 15:47:05",
        "description": "Alembic Pharma Q1FY27 results: Net profit rises 12% to 173 crore  Business Standard..."
      },
      {
        "title": "Alembic Pharma gains after partner NATCO receives USFDA tentative nod for Olaparib tablets",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-20 16:04:06",
        "description": "Alembic Pharma gains after partner NATCO receives USFDA tentative nod for Olaparib tablets  Business Standard..."
      },
      {
        "title": "Alembic Pharma gains after partner NATCO receives USFDA tentative nod for Olaparib tablets",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-20 16:04:06",
        "description": "Alembic Pharma gains after partner NATCO receives USFDA tentative nod for Olaparib tablets  Business Standard..."
      },
      {
        "title": "Stocks to watch: JSW Steel, Alembic Pharma, Cipla, Laser Power, 5Paisa, Prestige Estates, NBCC (India)",
        "link": "https://news.google.com/rss/articles/CBMioAJBVV95cUxNU1Vadm0ydzEzc2NVV29tSHRGVFQzWXdNaHpSZXdUZzVGT1lqT1d4REVtZDdZa3FaV1BOOFFnYy0zQXFOSFZMSnRzc2E0NzV2cGN0UFpqREZKMTZZR1FwY0R0M2tTSXY5VFZLTG1jdXpnRzMzYXkzc3dDSDdKbkNEb2xoVUlGTXU5bmZNTzJLbVA1d21zQmJoTkY2d0psTzRjS2pjYXRLcXB1Y0lSZXhtQldnRnBTRUZVbUc5RGl2bjNvMHE2UXBGdjN1dnhIWkFDb0pXNnNXaERzZGRKUDUyNGZGb3RHd3ZZZkR1UGl6RjJLeTRWb2VpX1RtVXVhbW5nT2lLZkxfWGF5VVkyeW5WMWdUdU94UVdSMmJibV9GMW8?oc=5",
        "imagepath": "",
        "date": "2026-07-20 07:08:26",
        "description": "Stocks to watch: JSW Steel, Alembic Pharma, Cipla, Laser Power, 5Paisa, Prestige Estates, NBCC (India)  BusinessLine..."
      },
      {
        "title": "Stocks to watch: JSW Steel, Alembic Pharma, Cipla, Laser Power, 5Paisa, Prestige Estates, NBCC (India)",
        "link": "https://news.google.com/rss/articles/CBMioAJBVV95cUxNU1Vadm0ydzEzc2NVV29tSHRGVFQzWXdNaHpSZXdUZzVGT1lqT1d4REVtZDdZa3FaV1BOOFFnYy0zQXFOSFZMSnRzc2E0NzV2cGN0UFpqREZKMTZZR1FwY0R0M2tTSXY5VFZLTG1jdXpnRzMzYXkzc3dDSDdKbkNEb2xoVUlGTXU5bmZNTzJLbVA1d21zQmJoTkY2d0psTzRjS2pjYXRLcXB1Y0lSZXhtQldnRnBTRUZVbUc5RGl2bjNvMHE2UXBGdjN1dnhIWkFDb0pXNnNXaERzZGRKUDUyNGZGb3RHd3ZZZkR1UGl6RjJLeTRWb2VpX1RtVXVhbW5nT2lLZkxfWGF5VVkyeW5WMWdUdU94UVdSMmJibV9GMW_SAacCQVVfeXFMTTZ5NEQzYVVBTkdlOGxWVi1WQ3FENlpfY2dMcU5iVy1hNV96S0lobWlJcDktUjlocjRpeVFZbzFiTGh1cjlVa3JBSDBVYnRqeTFmSmY3V256T1dZNUlTRURDSUpROXY3dlUyY0NLVEZNdEViZWxnUUZ6T0d3bW92NTd6YWVTRWcwZnkwUUFaclNfUHFFek5SZ1ZPS3hNeWxNR0NnSWJreWJuR29zSHppeFRKTXJSTnRZM1ROUjZJVVdUeWhKYVpfZ0lXSkxrVWNkb3BuekFCSENGbGZDdDFEc3dLd1dUN3drUmVrWnhpUzRXM3BueHFQaW9vdHk4aFc4blBGT29WcEFvd1dnVTVFVXZDamMtWm9OemItXzRTMUpabWkydlktbw?oc=5",
        "imagepath": "",
        "date": "2026-07-20 07:08:26",
        "description": "Stocks to watch: JSW Steel, Alembic Pharma, Cipla, Laser Power, 5Paisa, Prestige Estates, NBCC (India)  BusinessLine..."
      }
    ],
    "total": 6,
    "sid": "807696",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/alembic-pharmaceuticals-807696"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "06-Aug-2026",
      "details": "Please find attached herewith the Scrutinizer Report and Voting Results of the AGM held on 5th August 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-Aug-2026",
      "details": "Please find attached herewith the Newspaper Advertisement.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "05-Aug-2026",
      "details": "Please find attached Proceedings of AGM held on 5th August 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alembic Pharmaceuticals Ltd. has declared <strong>600%</strong> dividend, ex-date: 29 Jul 26",
          "dt": "2026-07-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Shareholder Meeting / Postal Ballot-Scrutinizers Report

06-Aug-2026 | Source : BSE

Please find attached herewith the Scrutinizer Report and Voting Results of the AGM held on 5th August 2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication

05-Aug-2026 | Source : BSE

Please find attached herewith the Newspaper Advertisement.

Shareholder Meeting / Postal Ballot-Outcome of AGM

05-Aug-2026 | Source : BSE

Please find attached Proceedings of AGM held on 5th August 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alembic Pharmaceuticals Ltd. has declared 600% dividend, ex-date: 29 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available